SignatureFD
MDGL icon

SignatureFD’s Madrigal Pharmaceuticals MDGL Stock Holding History

SignatureFD’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$68.5K Buy
136
+2
+1% +$1.06K ﹤0.01% 1778
2026
Q2 		$72K Buy
134
+7
+6% +$3.59K ﹤0.01% 1650
2026
Q1 		$66.5K Buy
127
+12
+10% +$5.73K ﹤0.01% 1555
2025
Q4 		$67K Hold
115
– – ﹤0.01% 1497
2025
Q3 		$52.7K Sell
115
-11
-9% -$4.1K ﹤0.01% 1616
2025
Q2 		$38.1K Sell
126
-10
-7% -$2.98K ﹤0.01% 1734
2025
Q1 		$45K Buy
136
+3
+2% +$986 ﹤0.01% 1629
2024
Q4 		$41K Sell
133
-6
-4% -$1.69K ﹤0.01% 1689
2024
Q3 		$29.5K Sell
139
-6
-4% -$1.54K ﹤0.01% 1856
2024
Q2 		$40.6K Buy
145
+39
+37% +$9.28K ﹤0.01% 1616
2024
Q1 		$28.3K Buy
106
+4
+4% +$942 ﹤0.01% 1824
2023
Q4 		$23.6K Buy
102
+10
+11% +$1.75K ﹤0.01% 1842
2023
Q3 		$13.4K Buy
92
+53
+136% +$10K ﹤0.01% 2050
2023
Q2 		$9.01K Hold
39
– – ﹤0.01% 2280
2023
Q1 		$9.45K Hold
39
– – ﹤0.01% 2238
2022
Q4 		$11.3K Buy
+39
New +$3.81K ﹤0.01% 2089
2022
Q1 		– Sell
-54
Closed -$5K – 3253
2021
Q4 		$5K Buy
54
+50
+1,250% +$4.11K ﹤0.01% 2400
2021
Q3 		$0 Sell
4
-33
-89% -$2.85K ﹤0.01% 3146
2021
Q2 		$4K Sell
37
-8
-18% -$947 ﹤0.01% 2361
2021
Q1 		$5K Buy
+45
New +$5.25K ﹤0.01% 2144
2020
Q3 		– Sell
-7
Closed -$1K – 2696
2020
Q2 		$1K Buy
+7
New +$688 ﹤0.01% 2337

Other funds holding MDGL

EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bourgeon Capital Management
Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return
Shikiar Asset Management
Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

SignatureFD's MDGL Position: Q3 2026 in Review

SignatureFD increased its Madrigal Pharmaceuticals (MDGL) stake by 1.5% in Q3 2026, buying an estimated $1.06K and bringing the position to 136 shares worth $68.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

SignatureFD first reported a position in MDGL in Q2 2020 and has held it in 21 quarters since. The position peaked at $72K in Q2 2026. 67 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • SignatureFD held 136 shares of Madrigal Pharmaceuticals worth $68.5K as of Q3 2026.
  • SignatureFD bought 2 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $1.06K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1778 holding.
  • SignatureFD first reported a position in Madrigal Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
  • SignatureFD's Madrigal Pharmaceuticals position peaked at $72K in Q2 2026.
  • 67 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.